Macrophage Stimulating Factor in the Treatment of Diabetic Wounds

NARecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 12, 2024

Primary Completion Date

November 12, 2025

Study Completion Date

May 31, 2026

Conditions
Diabetic Wound
Interventions
DRUG

Topical Human Granulocyte Macrophage Stimulating Factor Gel

Human granulocyte macrophage colony-stimulating factor (rhGM-CSF), as a multifunctional haematopoietic factor, stimulates the proliferation and differentiation of haematopoietic precursor cells to granulocyte macrophages and promotes their peripheral translocation, as well as enhances phagocytosis and secretion of granulocytes and macrophages \[11\]. Since macrophages are key players in regulating the inflammatory response of wounds and promoting wound repair, rhGM-CSF is thought to potentially play a positive role in the treatment of acute and chronic wounds.

DRUG

Saline (NaCl 0,9 %) (placebo)

placebo

Trial Locations (1)

100191

RECRUITING

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER